We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current PMVP market cap is 78.31M. The company's latest EPS is USD -1.3385 and P/E is -1.14.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -21.48M | -20.12M | -19.63M | -18.9M | -18.22M |
| Net Income | -19.13M | -17.44M | -16.64M | -15.76M | -15.27M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -26.64M | -34.94M | -58.29M | -77.04M | -80.13M |
| Net Income | -25.35M | -34.44M | -57.85M | -73.32M | -68.96M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 253.96M | 242.22M | 261.03M | 252.15M | 236.88M |
| Total Liabilities | 23.79M | 24.41M | 23.42M | 26.46M | 24.2M |
| Total Equity | 230.17M | 217.81M | 237.61M | 225.69M | 212.68M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 103.03M | 365.53M | 331.57M | 270.31M | 252.15M |
| Total Liabilities | 4.57M | 6.41M | 23.01M | 24.28M | 26.46M |
| Total Equity | -70.47M | 359.12M | 308.56M | 246.03M | 225.69M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -15.01M | -27.91M | -43.57M | -55.66M | -16.18M |
| Investing | 49.65M | -14.32M | -47.96M | -50.55M | 26.17M |
| Financing | 12k | 2.14M | 35.29M | 35.58M | N/A |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -22.07M | -32.74M | -46.57M | -63.76M | -55.66M |
| Investing | 3.23M | 27.91M | -143.58M | -1.37M | -50.55M |
| Financing | 61.81M | 292.97M | 2.02M | 958k | 35.58M |
| Market Cap | 78.31M |
| Price to Earnings Ratio | -1.14 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.08 |
| Price to Book Ratio | 0.35 |
| Dividend Yield | - |
| Shares Outstanding | 51.52M |
| Average Volume (1 week) | 106.93k |
| Average Volume (1 Month) | 236.51k |
| 52 Week Change | -74.92% |
| 52 Week High | 6.98 |
| 52 Week Low | 1.175 |
| Spread (Intraday) | 0.15 (8.88%) |
| Company Name | PMV Pharmaceuticals Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.pmvpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
